Gador Sa, based in Argentina, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is 17-DEACETYL NORGESTIMATE, with a corresponding US DMF Number 20004.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2020, and payment made on June 11, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II